NCT00778921View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone

PHASE3CompletedINTERVENTIONAL
Enrollment

847

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Hypertension
Interventions
DRUG

Amlodipine 10 mg

Amlodipine 10 mg

DRUG

Aliskiren 150

Aliskiren/Amlodipine 150/10 mg

DRUG

Amlodipine 300

Aliskiren/Amlodipine 300/10 mg

Trial Locations (7)

Unknown

Investigative Site, Buenos Aires

Investigative Site, Berlin

Investigative Site, Oslo

Investigative Site, Warsaw

Investigative Site, Bratislava

Investigative Site, Stockholm

Investigative Site, Ankara

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00778921 - Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone | Biotech Hunter | Biotech Hunter